Cơ Chế Tác Dụng :
SC12267 is a novel, small molecule agent from the class of DMARDs (disease modifying anti-rheumatic drug) for the therapy of autoimmune diseases such as rheumatoid arthritis or multiple sclerosis. Through highly selective inhibition of pyrimidine biosynthesis, it controls the growth of rapidly proliferating cells, especially of lymphocytes, which are important for the immune response.
SC12267, a novel, selective and orally available, small molecule inhibitor of dihydroorotate dehydrogenase
(DHODH), interferes with cell proliferation through blocking the synthesis pathway of pyrimidines. Its mode-of-
action is of therapeutic relevance for the treatment of autoimmune disorders such as rheumatoid arthritis and
multiple sclerosis.
Chỉ Định :
Investigated for use/treatment in multiple sclerosis and rheumatoid arthritis.